Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1996-04-05
1999-12-21
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544105, A61K 31535, C07D26536
Patent
active
060049561
ABSTRACT:
The invention relates to enantiomerically pure 2-oxa-5,8-diazabicyclo[4.3.0]nonanes and processes for their preparation.
REFERENCES:
patent: 4634775 (1987-01-01), Wolfgang et al.
patent: 4990517 (1991-02-01), Peterson et al.
patent: 5468742 (1995-11-01), Peterson et al.
Chem. Pharm. Bull. 17(5) 980-086 (1969); Syntheses of 3,4-Epoxy- and 3,4-Epimino-pyrrolidines).
Zh. Org. Khim. 3, 1509 (1967); Synthesis of Pyrrolidine, Pyrroline, and Pyrrole Derivatives Based on Sulfur Arysulfonylmonoimino Dioxides.
J. Chem. Research (S), 1989, 224-225; Applications of Phase Transfer Catalysis. Part 47. Relative Stabilities and Performances of Various Phase Transfer Catalysts.
Rosario et al., 1989, Neurosci. 29, 735-747.
Carbone et al., 1990, Pflugers Arch., 416:170-179.
Zernig et al., 1986, Eur. J. Pharmacol. 128, 221-229.
Lacerda et al., 1991, Nature 352:527.
Veradi et al., 1991, Nature 352:159.
Ruth et al., 1989, Science 245:1115.
Tsien et al., 1988, Trends in Neurol. Sci., 11:431-438.
Tanabe et al., 1987, Nature 328:313-318.
Singer et al., 1991, Science 253:1553.
P.Ruth et al., "Primary Structure . . . Skeletal Muscle", Reports, Sep. 8, 1989, pp. 1115-1118.
D. Singer et al., "The roles . . . Calcium Channel", Reports, Sep. 27, 1991, pp. 1553-1557.
T. Tannabe et al., "Primary Structure of the Receptor . . . Muscle", Nature, vol. 328, Jul. 23, 1987, pp. 313-318.
Nakagawa et al, Ca, vol. 116, No. 21064 (1992) (Abstract for JP 03,188,080, Aug. 16. 1991).
Takemura et al, Ca, vol. 122, No. 81351 (1995) (Abstract for EP 603,887, Jun. 29, 1994).
Patai, The Chemistry of the ether linkage Interscience, 1967, G. Kohnstam and D.K.H. Williams, pp. 118-120.
Patai, The Chemistry of the Sulphonium group Interscience, 1981, D.C. Dittmer & B.H. Patwardham, pp. 394-395.
Angew. Chem. Internat. Edit., vol. 2, 1963, No. 11, pp. 674-683.
Thioethers; Differences and Analogies w/ Ethers, pp. 591-594 L. Brandsma & J.F. Arens.
Academic Press, 1978, pp. 217-220; Phase Transfer Catalysis.
Angew. Chem 92, 14-25 (1980); Chromatographische Racemattrennung.
Yool and Schwarz, 1991, Nature 349: 700-704.
P.A. Powers et al., "Skeletal Muscle . . . Single Gene", The Journal of Biological Chemistry, vol. 267, No. 32, Nov. 15, 1992, pp. 22967-22972.
H. Perst, Oxanium Ions in Organic Chemistry Weinheim, 1971, p. 101.
Conant, The Chemistry of Organic Compounds, 5th Ed. (1959), p. 333.
Gluzman, 1981, Cell 23:175.
Chen et al., 1987, Mol. Cell. Biol. 7:2745-2752.
Messing et al., 1985, J. Pharmacology and Exp. Therapeutics 235:407-411.
Krebs Andreas
Petersen Uwe
Schenke Thomas
Bayer Aktiengesellschaft
Shah Mukund J.
Truong Tamthom N.
LandOfFree
Enantiomerically pure 2-oxa-5,8-dizaabicyclo[4.3.0] nonanes and does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enantiomerically pure 2-oxa-5,8-dizaabicyclo[4.3.0] nonanes and , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enantiomerically pure 2-oxa-5,8-dizaabicyclo[4.3.0] nonanes and will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-505324